Status:
COMPLETED
HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population
Lead Sponsor:
Focus Diagnostics, Inc.
Conditions:
Herpes Simplex Virus 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is designed to compare the performance of the Focus Diagnostics' HerpeSelect® Express, a Herpes Simplex Virus 2 Rapid Test, to a currently marketed device. The intent is to show the rapid t...
Detailed Description
The objective of this study is to establish the performance characteristics of the Focus Diagnostics (Focus) HerpeSelect® Express based on comparison to the Focus Diagnostics' HerpeSelect® 2 ELISA IgG...
Eligibility Criteria
Inclusion
- Sexually Active Adults - Intercourse in the last twelve months with at least one sexual partner.
- Subjects must be ≥ 18 years old.
- No more than 60% of one gender.
Exclusion
- \<18 years old
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00655434
Start Date
March 1 2008
End Date
May 1 2008
Last Update
January 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Clinical Research
Burbank, California, United States, 91505